SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis

Joseph P. Ritchie, Vishnu C. Ramani, Yongsheng Ren, +11

Clinical Cancer Research

Syndecan-1 Is Required for Robust Growth, Vascularization, and Metastasis of Myeloma Tumors in Vivo

Yekaterina B. Khotskaya, Yuemeng Dai, Joseph P. Ritchie, +4

Journal of Biological Chemistry

Inhibition of Transforming Growth Factor-β Activation Diminishes Tumor Progression and Osteolytic Bone Disease in Mouse Models of Multiple Myeloma

Ailing Lu, Manuel A. Pallero, Weiqi Lei, +4

American Journal Of Pathology

Tumor BiologyBone Morphogenic ProteinMouse ModelsMultiple MyelomaOsteocalcin +5

Myeloma cell–derived Runx2 promotes myeloma progression in bone

Timothy N. Trotter, Mei Li, Qianying Pan, +7

Blood

Runx2 Suppression by miR-342 and miR-363 Inhibits Multiple Myeloma Progression

Pramod S. Gowda, Benjamin J. Wildman, Timothy N. Trotter, +4

Molecular Cancer Research

Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study

Junyu Liang, Heng Cao, Yang Yang, +5

Frontiers in Medicine

Clinical Study of Autologous Cytokine-Induced Killer Cells for the Treatment of Elderly Patients with Diffuse Large B-Cell Lymphoma

Xue-Chun Lu, Bo Yang, Ruili Yu, +14

Cell Biochemistry and Biophysics

Lymphoid NeoplasiaAutoimmune DiseaseElderly PatientsMalignant Blood DisorderHematology +7

Therapeutic effects of the novel subtype-selective histone deacetylase inhibitor chidamide on myeloma-associated bone disease

Jingsong He, Qingxiao Chen, Huiyao Gu, +12

Haematologica

BAFF is involved in macrophage-induced bortezomib resistance in myeloma

Jing Chen, Donghua He, Qingxiao Chen, +10

Cell Death and Disease

Multiple Extramedullary-Bone Related and/or Extramedullary Extraosseous Are Independent Poor Prognostic Factors in Patients With Newly Diagnosed Multiple Myeloma

Jingsong He, Xiaoyan Yue, Donghua He, +9

Frontiers in Oncology